Ezesufura Tablets (Ezetimibe, Fenofibrate)

Adult dose

The dosage for adults is one tablet taken immediately after a meal once daily. Since fenofibrate, one of the components of this medication, may be less absorbed on an empty stomach, it must be taken immediately after a meal.

This medication should not be used in certain patients. First, patients with allergies to this medication or its components should not be administered this drug. Patients with liver problems or persistent liver dysfunction, and women who are pregnant or breastfeeding should also avoid using this medication. In addition, patients with moderate to severe renal impairment, gallbladder disorders, children, and those with pancreatitis should not take this medication. This medication contains lactose and should not be administered to patients with lactose intolerance. Patients with mild kidney impairment or liver dysfunction, patients with hypoalbuminemia, patients with a history of gallstones, patients taking anticoagulants, and elderly patients should use this medication cautiously. Particularly, caution is required regarding potential drug interactions and adverse reactions. This medication may cause side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain, while rare occurrences of liver dysfunction, myopathy, and allergic reactions have been reported. If any unusual symptoms appear, consult a physician immediately. Regular tests for liver and kidney function should be conducted, and administration may be discontinued if symptoms worsen or if strange signs occur. Women who are pregnant or may become pregnant, as well as breastfeeding mothers, should not take this medication. This medication should not be used in children, and elderly patients should be carefully administered based on their kidney and liver function status. In case of overdose, there is no specific antidote, and appropriate treatment should be provided based on symptoms. This medication should be kept out of the reach of children, and it is safe not to transfer it to another container.

Serious side effects

Urticaria, angioedema, rash, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, liver dysfunction, hepatitis, pancreatitis, urticaria, photosensitive eczema, phototoxicity, photoreaction, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), acute hypersensitivity reactions, DRESS syndrome, thrombocytopenia, agranulocytosis, ventricular arrhythmias, renal failure, deterioration of renal function, rhabdomyolysis, myopathy, serum amino transferase elevation

Mild side effects

• Fatigue
• abdominal pain
• diarrhea
• viral infections
• pharyngitis
• sinusitis
• joint pain
• back pain
• cough
• chest pain

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature.

Appearance

White, round, film-coated tablet

Package unit

30 tablets/PTP [(10 tablets/PTP×3)], 30 tablets/bottle, 100 tablets/bottle